FDA questions data for J&J ovarian cancer drug

Courtesy Newsvine - business  Mon, 07/13/2009 - 08:20

Food and Drug Administration scientists are questioning whether study results are reliable enough to warrant approval for a new cancer drug from Johnson & Johnson.


 

Related items

Mead Johnson Says Its Tests Show Enfamil Baby Formula...
Mead Johnson Nutrition Co. said tests it conducted on samples of its Enfamil baby formula tied to an U.S. Food and Drug Administration investigation found no presence of bacteria.

Medical Device Makers Shun U.S.
Medical device executives say regulation by the Food and Drug Administration has hurt the industry domestically.

AP Enterprise: FDA helps states get execution drug
The Food and Drug Administration helped Arizona and California obtain a quick overseas source of a hard-to-find execution drug even as the agency declared it would not regulate or block...

Hunt(R) Boston(R) 1800 Series Electric Sharpener,...
1800 Series Desktop Electric Pencil Sharpener, Charcoal Black / Sharpener with a compact design, yet full-size capability. X-ACTO steel blades ensure a high-quality sharpening each time....

SLIM CLIP
Slim ClipTM conveniently holds cash and credit cards in a modern, sleek design.Dual sides securely holds up to six credit or I.D. cards and 30 bills. Great for receipts and business cards,...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
CAPTCHA
We apologize for the inconvenience. Please help fight spam.
business.marc8.com